Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 7,990.00
-160.00 (-1.96%)
At close: Jun 19, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 67.26 billion as of June 18, 2026. Its market cap has decreased by -24.78% in one year.
Market Cap
67.26B
Enterprise Value
n/a
Revenue
107.87B
Ranking
n/a
PE Ratio
16.84
Stock Price
7,990.00
Market Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 67.26B, an increase of 172.57%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 67.26B | -30.77% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samik Pharmaceutical Company LTD. | 84.16B |
| Sam-A Pharm. | 81.36B |
| Pharos iBio | 81.04B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Sinsin Pharmaceutical | 68.42B |
| Optipharm.CO.,LTD | 67.12B |